Request for Covid-19 Impact Assessment of this Report
The United States Pharmaceutical Isolating and Containment Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmaceutical Isolating and Containment Systems market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Isolating and Containment Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pharmaceutical Isolating and Containment Systems players cover SKAN, Extract Technology, Bioquell, and Tofflon, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Isolating and Containment Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Production Isolating and Containment Systems
Testing Isolating and Containment Systems
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
SKAN
Extract Technology
Bioquell
Tofflon
Getinge
Syntegon
Comecer
ISOTECH
Weike
Azbil Telstar
Fedegari Autoclavi
Hosokawa Micron
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Isolating and Containment Systems Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pharmaceutical Isolating and Containment Systems by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pharmaceutical Isolating and Containment Systems by Country/Region, 2017, 2022 & 2028
2.2 Pharmaceutical Isolating and Containment Systems Segment by Type
2.2.1 Production Isolating and Containment Systems
2.2.2 Testing Isolating and Containment Systems
2.3 Pharmaceutical Isolating and Containment Systems Sales by Type
2.3.1 Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2017-2022)
2.3.2 Global Pharmaceutical Isolating and Containment Systems Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pharmaceutical Isolating and Containment Systems Sale Price by Type (2017-2022)
2.4 Pharmaceutical Isolating and Containment Systems Segment by Application
2.4.1 Academic and Research Institutes
2.4.2 Pharmaceutical and Biotechnology Companies
2.4.3 Others
2.5 Pharmaceutical Isolating and Containment Systems Sales by Application
2.5.1 Global Pharmaceutical Isolating and Containment Systems Sale Market Share by Application (2017-2022)
2.5.2 Global Pharmaceutical Isolating and Containment Systems Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pharmaceutical Isolating and Containment Systems Sale Price by Application (2017-2022)
3 Global Pharmaceutical Isolating and Containment Systems by Company
3.1 Global Pharmaceutical Isolating and Containment Systems Breakdown Data by Company
3.1.1 Global Pharmaceutical Isolating and Containment Systems Annual Sales by Company (2020-2022)
3.1.2 Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Company (2020-2022)
3.2 Global Pharmaceutical Isolating and Containment Systems Annual Revenue by Company (2020-2022)
3.2.1 Global Pharmaceutical Isolating and Containment Systems Revenue by Company (2020-2022)
3.2.2 Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Company (2020-2022)
3.3 Global Pharmaceutical Isolating and Containment Systems Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Isolating and Containment Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Isolating and Containment Systems Product Location Distribution
3.4.2 Players Pharmaceutical Isolating and Containment Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Isolating and Containment Systems by Geographic Region
4.1 World Historic Pharmaceutical Isolating and Containment Systems Market Size by Geographic Region (2017-2022)
4.1.1 Global Pharmaceutical Isolating and Containment Systems Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pharmaceutical Isolating and Containment Systems Annual Revenue by Geographic Region
4.2 World Historic Pharmaceutical Isolating and Containment Systems Market Size by Country/Region (2017-2022)
4.2.1 Global Pharmaceutical Isolating and Containment Systems Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pharmaceutical Isolating and Containment Systems Annual Revenue by Country/Region
4.3 Americas Pharmaceutical Isolating and Containment Systems Sales Growth
4.4 APAC Pharmaceutical Isolating and Containment Systems Sales Growth
4.5 Europe Pharmaceutical Isolating and Containment Systems Sales Growth
4.6 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Growth
5 Americas
5.1 Americas Pharmaceutical Isolating and Containment Systems Sales by Country
5.1.1 Americas Pharmaceutical Isolating and Containment Systems Sales by Country (2017-2022)
5.1.2 Americas Pharmaceutical Isolating and Containment Systems Revenue by Country (2017-2022)
5.2 Americas Pharmaceutical Isolating and Containment Systems Sales by Type
5.3 Americas Pharmaceutical Isolating and Containment Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Isolating and Containment Systems Sales by Region
6.1.1 APAC Pharmaceutical Isolating and Containment Systems Sales by Region (2017-2022)
6.1.2 APAC Pharmaceutical Isolating and Containment Systems Revenue by Region (2017-2022)
6.2 APAC Pharmaceutical Isolating and Containment Systems Sales by Type
6.3 APAC Pharmaceutical Isolating and Containment Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Isolating and Containment Systems by Country
7.1.1 Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2017-2022)
7.1.2 Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2017-2022)
7.2 Europe Pharmaceutical Isolating and Containment Systems Sales by Type
7.3 Europe Pharmaceutical Isolating and Containment Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Isolating and Containment Systems by Country
8.1.1 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2017-2022)
8.2 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Type
8.3 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Isolating and Containment Systems
10.3 Manufacturing Process Analysis of Pharmaceutical Isolating and Containment Systems
10.4 Industry Chain Structure of Pharmaceutical Isolating and Containment Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Isolating and Containment Systems Distributors
11.3 Pharmaceutical Isolating and Containment Systems Customer
12 World Forecast Review for Pharmaceutical Isolating and Containment Systems by Geographic Region
12.1 Global Pharmaceutical Isolating and Containment Systems Market Size Forecast by Region
12.1.1 Global Pharmaceutical Isolating and Containment Systems Forecast by Region (2023-2028)
12.1.2 Global Pharmaceutical Isolating and Containment Systems Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Isolating and Containment Systems Forecast by Type
12.7 Global Pharmaceutical Isolating and Containment Systems Forecast by Application
13 Key Players Analysis
13.1 SKAN
13.1.1 SKAN Company Information
13.1.2 SKAN Pharmaceutical Isolating and Containment Systems Product Offered
13.1.3 SKAN Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 SKAN Main Business Overview
13.1.5 SKAN Latest Developments
13.2 Extract Technology
13.2.1 Extract Technology Company Information
13.2.2 Extract Technology Pharmaceutical Isolating and Containment Systems Product Offered
13.2.3 Extract Technology Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Extract Technology Main Business Overview
13.2.5 Extract Technology Latest Developments
13.3 Bioquell
13.3.1 Bioquell Company Information
13.3.2 Bioquell Pharmaceutical Isolating and Containment Systems Product Offered
13.3.3 Bioquell Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bioquell Main Business Overview
13.3.5 Bioquell Latest Developments
13.4 Tofflon
13.4.1 Tofflon Company Information
13.4.2 Tofflon Pharmaceutical Isolating and Containment Systems Product Offered
13.4.3 Tofflon Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Tofflon Main Business Overview
13.4.5 Tofflon Latest Developments
13.5 Getinge
13.5.1 Getinge Company Information
13.5.2 Getinge Pharmaceutical Isolating and Containment Systems Product Offered
13.5.3 Getinge Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Getinge Main Business Overview
13.5.5 Getinge Latest Developments
13.6 Syntegon
13.6.1 Syntegon Company Information
13.6.2 Syntegon Pharmaceutical Isolating and Containment Systems Product Offered
13.6.3 Syntegon Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Syntegon Main Business Overview
13.6.5 Syntegon Latest Developments
13.7 Comecer
13.7.1 Comecer Company Information
13.7.2 Comecer Pharmaceutical Isolating and Containment Systems Product Offered
13.7.3 Comecer Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Comecer Main Business Overview
13.7.5 Comecer Latest Developments
13.8 ISOTECH
13.8.1 ISOTECH Company Information
13.8.2 ISOTECH Pharmaceutical Isolating and Containment Systems Product Offered
13.8.3 ISOTECH Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ISOTECH Main Business Overview
13.8.5 ISOTECH Latest Developments
13.9 Weike
13.9.1 Weike Company Information
13.9.2 Weike Pharmaceutical Isolating and Containment Systems Product Offered
13.9.3 Weike Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Weike Main Business Overview
13.9.5 Weike Latest Developments
13.10 Azbil Telstar
13.10.1 Azbil Telstar Company Information
13.10.2 Azbil Telstar Pharmaceutical Isolating and Containment Systems Product Offered
13.10.3 Azbil Telstar Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Azbil Telstar Main Business Overview
13.10.5 Azbil Telstar Latest Developments
13.11 Fedegari Autoclavi
13.11.1 Fedegari Autoclavi Company Information
13.11.2 Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Product Offered
13.11.3 Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fedegari Autoclavi Main Business Overview
13.11.5 Fedegari Autoclavi Latest Developments
13.12 Hosokawa Micron
13.12.1 Hosokawa Micron Company Information
13.12.2 Hosokawa Micron Pharmaceutical Isolating and Containment Systems Product Offered
13.12.3 Hosokawa Micron Pharmaceutical Isolating and Containment Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hosokawa Micron Main Business Overview
13.12.5 Hosokawa Micron Latest Developments
14 Research Findings and Conclusion
Table 1. Pharmaceutical Isolating and Containment Systems Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pharmaceutical Isolating and Containment Systems Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Production Isolating and Containment Systems
Table 4. Major Players of Testing Isolating and Containment Systems
Table 5. Global Pharmaceutical Isolating and Containment Systems Sales by Type (2017-2022) & (K Units)
Table 6. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2017-2022)
Table 7. Global Pharmaceutical Isolating and Containment Systems Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2017-2022)
Table 9. Global Pharmaceutical Isolating and Containment Systems Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pharmaceutical Isolating and Containment Systems Sales by Application (2017-2022) & (K Units)
Table 11. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2017-2022)
Table 12. Global Pharmaceutical Isolating and Containment Systems Revenue by Application (2017-2022)
Table 13. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2017-2022)
Table 14. Global Pharmaceutical Isolating and Containment Systems Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pharmaceutical Isolating and Containment Systems Sales by Company (2020-2022) & (K Units)
Table 16. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Company (2020-2022)
Table 17. Global Pharmaceutical Isolating and Containment Systems Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Company (2020-2022)
Table 19. Global Pharmaceutical Isolating and Containment Systems Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pharmaceutical Isolating and Containment Systems Producing Area Distribution and Sales Area
Table 21. Players Pharmaceutical Isolating and Containment Systems Products Offered
Table 22. Pharmaceutical Isolating and Containment Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pharmaceutical Isolating and Containment Systems Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Pharmaceutical Isolating and Containment Systems Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pharmaceutical Isolating and Containment Systems Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pharmaceutical Isolating and Containment Systems Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pharmaceutical Isolating and Containment Systems Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pharmaceutical Isolating and Containment Systems Sales by Country (2017-2022) & (K Units)
Table 34. Americas Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2017-2022)
Table 35. Americas Pharmaceutical Isolating and Containment Systems Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2017-2022)
Table 37. Americas Pharmaceutical Isolating and Containment Systems Sales by Type (2017-2022) & (K Units)
Table 38. Americas Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2017-2022)
Table 39. Americas Pharmaceutical Isolating and Containment Systems Sales by Application (2017-2022) & (K Units)
Table 40. Americas Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2017-2022)
Table 41. APAC Pharmaceutical Isolating and Containment Systems Sales by Region (2017-2022) & (K Units)
Table 42. APAC Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2017-2022)
Table 43. APAC Pharmaceutical Isolating and Containment Systems Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pharmaceutical Isolating and Containment Systems Revenue Market Share by Region (2017-2022)
Table 45. APAC Pharmaceutical Isolating and Containment Systems Sales by Type (2017-2022) & (K Units)
Table 46. APAC Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2017-2022)
Table 47. APAC Pharmaceutical Isolating and Containment Systems Sales by Application (2017-2022) & (K Units)
Table 48. APAC Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2017-2022)
Table 49. Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2017-2022) & (K Units)
Table 50. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2017-2022)
Table 51. Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2017-2022)
Table 53. Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2017-2022) & (K Units)
Table 54. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2017-2022)
Table 55. Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2017-2022) & (K Units)
Table 56. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pharmaceutical Isolating and Containment Systems
Table 66. Key Market Challenges & Risks of Pharmaceutical Isolating and Containment Systems
Table 67. Key Industry Trends of Pharmaceutical Isolating and Containment Systems
Table 68. Pharmaceutical Isolating and Containment Systems Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pharmaceutical Isolating and Containment Systems Distributors List
Table 71. Pharmaceutical Isolating and Containment Systems Customer List
Table 72. Global Pharmaceutical Isolating and Containment Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Pharmaceutical Isolating and Containment Systems Sales Market Forecast by Region
Table 74. Global Pharmaceutical Isolating and Containment Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pharmaceutical Isolating and Containment Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Pharmaceutical Isolating and Containment Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pharmaceutical Isolating and Containment Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Pharmaceutical Isolating and Containment Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pharmaceutical Isolating and Containment Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Pharmaceutical Isolating and Containment Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pharmaceutical Isolating and Containment Systems Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Pharmaceutical Isolating and Containment Systems Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pharmaceutical Isolating and Containment Systems Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pharmaceutical Isolating and Containment Systems Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Pharmaceutical Isolating and Containment Systems Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pharmaceutical Isolating and Containment Systems Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share Forecast by Application (2023-2028)
Table 92. SKAN Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 93. SKAN Pharmaceutical Isolating and Containment Systems Product Offered
Table 94. SKAN Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. SKAN Main Business
Table 96. SKAN Latest Developments
Table 97. Extract Technology Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 98. Extract Technology Pharmaceutical Isolating and Containment Systems Product Offered
Table 99. Extract Technology Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Extract Technology Main Business
Table 101. Extract Technology Latest Developments
Table 102. Bioquell Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 103. Bioquell Pharmaceutical Isolating and Containment Systems Product Offered
Table 104. Bioquell Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Bioquell Main Business
Table 106. Bioquell Latest Developments
Table 107. Tofflon Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 108. Tofflon Pharmaceutical Isolating and Containment Systems Product Offered
Table 109. Tofflon Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Tofflon Main Business
Table 111. Tofflon Latest Developments
Table 112. Getinge Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 113. Getinge Pharmaceutical Isolating and Containment Systems Product Offered
Table 114. Getinge Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Getinge Main Business
Table 116. Getinge Latest Developments
Table 117. Syntegon Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 118. Syntegon Pharmaceutical Isolating and Containment Systems Product Offered
Table 119. Syntegon Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Syntegon Main Business
Table 121. Syntegon Latest Developments
Table 122. Comecer Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 123. Comecer Pharmaceutical Isolating and Containment Systems Product Offered
Table 124. Comecer Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Comecer Main Business
Table 126. Comecer Latest Developments
Table 127. ISOTECH Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 128. ISOTECH Pharmaceutical Isolating and Containment Systems Product Offered
Table 129. ISOTECH Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. ISOTECH Main Business
Table 131. ISOTECH Latest Developments
Table 132. Weike Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 133. Weike Pharmaceutical Isolating and Containment Systems Product Offered
Table 134. Weike Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Weike Main Business
Table 136. Weike Latest Developments
Table 137. Azbil Telstar Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 138. Azbil Telstar Pharmaceutical Isolating and Containment Systems Product Offered
Table 139. Azbil Telstar Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Azbil Telstar Main Business
Table 141. Azbil Telstar Latest Developments
Table 142. Fedegari Autoclavi Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 143. Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Product Offered
Table 144. Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Fedegari Autoclavi Main Business
Table 146. Fedegari Autoclavi Latest Developments
Table 147. Hosokawa Micron Basic Information, Pharmaceutical Isolating and Containment Systems Manufacturing Base, Sales Area and Its Competitors
Table 148. Hosokawa Micron Pharmaceutical Isolating and Containment Systems Product Offered
Table 149. Hosokawa Micron Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Hosokawa Micron Main Business
Table 151. Hosokawa Micron Latest Developments
List of Figures
Figure 1. Picture of Pharmaceutical Isolating and Containment Systems
Figure 2. Pharmaceutical Isolating and Containment Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Isolating and Containment Systems Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pharmaceutical Isolating and Containment Systems Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pharmaceutical Isolating and Containment Systems Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Production Isolating and Containment Systems
Figure 10. Product Picture of Testing Isolating and Containment Systems
Figure 11. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type in 2021
Figure 12. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2017-2022)
Figure 13. Pharmaceutical Isolating and Containment Systems Consumed in Academic and Research Institutes
Figure 14. Global Pharmaceutical Isolating and Containment Systems Market: Academic and Research Institutes (2017-2022) & (K Units)
Figure 15. Pharmaceutical Isolating and Containment Systems Consumed in Pharmaceutical and Biotechnology Companies
Figure 16. Global Pharmaceutical Isolating and Containment Systems Market: Pharmaceutical and Biotechnology Companies (2017-2022) & (K Units)
Figure 17. Pharmaceutical Isolating and Containment Systems Consumed in Others
Figure 18. Global Pharmaceutical Isolating and Containment Systems Market: Others (2017-2022) & (K Units)
Figure 19. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2017-2022)
Figure 20. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application in 2021
Figure 21. Pharmaceutical Isolating and Containment Systems Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Company in 2021
Figure 23. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Geographic Region in 2021
Figure 25. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2017-2022)
Figure 26. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country/Region in 2021
Figure 27. Americas Pharmaceutical Isolating and Containment Systems Sales 2017-2022 (K Units)
Figure 28. Americas Pharmaceutical Isolating and Containment Systems Revenue 2017-2022 ($ Millions)
Figure 29. APAC Pharmaceutical Isolating and Containment Systems Sales 2017-2022 (K Units)
Figure 30. APAC Pharmaceutical Isolating and Containment Systems Revenue 2017-2022 ($ Millions)
Figure 31. Europe Pharmaceutical Isolating and Containment Systems Sales 2017-2022 (K Units)
Figure 32. Europe Pharmaceutical Isolating and Containment Systems Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue 2017-2022 ($ Millions)
Figure 35. Americas Pharmaceutical Isolating and Containment Systems Sales Market Share by Country in 2021
Figure 36. Americas Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country in 2021
Figure 37. United States Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Pharmaceutical Isolating and Containment Systems Sales Market Share by Region in 2021
Figure 42. APAC Pharmaceutical Isolating and Containment Systems Revenue Market Share by Regions in 2021
Figure 43. China Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Country in 2021
Figure 50. Europe Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country in 2021
Figure 51. Germany Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country in 2021
Figure 58. Egypt Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Pharmaceutical Isolating and Containment Systems Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Pharmaceutical Isolating and Containment Systems in 2021
Figure 64. Manufacturing Process Analysis of Pharmaceutical Isolating and Containment Systems
Figure 65. Industry Chain Structure of Pharmaceutical Isolating and Containment Systems
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...